21.10.Z - Manufacture of basic pharmaceutical substances
20.42.Z - Manufacture of perfumes and toilet preparations
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 723,1 | 147,1 | 8,8 | -94 |
Profit (loss) on sale | -415,6 | -595,8 | -90,2 | 84,9 |
Gross profit (loss) | -81,2 | -138,3 | -2,2 | 98,4 |
Net profit (loss) | -81,2 | -138,3 | -2,2 | 98,4 |
Cash | 629,3 | 119 | 4,2 | -96,5 |
Net income from sale | 0 | 1,5 | 12,7 | 744,2 |
Liabilities and provisions for liabilities | 576,8 | 139 | 2,8 | -98 |
Short time liabilities | 31,2 | 51 | 2,8 | -94,4 |
Other operating costs | 0 | 0 | 0 | -∞ |
Working assets | 720,6 | 144,6 | 6,3 | -95,7 |
Equity capital | 146,3 | 8,1 | 5,9 | -26,6 |
Other income costs | 334,4 | 457,6 | 88 | -80,8 |
Operating profit (EBIT) | -81,2 | -138,3 | -2,1 | 98,4 |
% | % | % | p.p. | |
Profitability of capital | -55,5 | -1712,8 | -36,3 | 1676,5 |
Equity capital to total assets | 20,2 | 5,5 | 67,6 | 62,1 |
Gross profit margin | -9217 | -17 | 9200 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 12 413 | 82 | -12 331 |
Current financial liquidity indicator | 23.123952865600586 | 2.834510326385498 | 2.2042653560638428 | -0,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane